Rigel Pharma (RIGL) Tops Q1 EPS by 63c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $46.82 -0.85%
Revenue Growth %: +15.2%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +15.2%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of $0.63. Revenue for the quarter came in at $53.33 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Iran Has Resumed Producing Ballistic Missiles, U.S. and Middle East Officials Say - WSJ
- Yelp adds OpenAI's GPT-Live-1 to restaurant and service tools
- GLJ Research rips into SolarEdge Technologies (SEDG): 'We'd be aggressively fading this move'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
